跳到正文
研踪PaperTrail
← 研踪 PaperTrail

arXiv:2603.15926 · v2

Auditing Path-Specific Fairness Across Causal Discovery Algorithms: A Heart Failure Case Study

首次提交 2026-03-17 05:19
版本更新 2026-11-18 13:43
雷达观测 2026-11-19 19:08
arXiv ↗PDF ↗

摘要

Causal discovery is increasingly applied to healthcare data, where the recovered relationships can encode biased pathways that propagate to downstream prediction. Path-specific fairness analysis, through direct, indirect, and spurious effect decompositions along with fairness-utility ratio assessment allows bias quantification and associated prediction cost. However, existing evaluations of causal discovery under fairness constraints have largely used non-clinical datasets and have not separated the contribution of confounders from that of mediators, leaving open how discovery-algorithm choice propagates through path-specific fairness to the utility trade-off in clinical settings. This work addresses that gap by establishing an expert-elicited causal graph benchmark for the heart failure clinical records dataset and tracing discovery algorithms through composite, per-variable fairness decompositions and fairness-utility ratio. ICA-LiNGAM achieves the lowest structural Hamming distance and highest recall, while GES achieves the highest precision. For path-specific effects, there was a 1.2 percentage-point difference in the mediated effect on ejection fraction on overall causal fairness between the original and discovered graphs. This ultimately led to variations in the fairness-utility ratio highlighting need for fine-grained evaluation. These results indicate that discovery-aware, path-specific fairness evaluation is consequential in clinical settings and warrants inclusion in routine auditing of clinical risk models.

AI 论文解读

基于摘要 · 非全文审阅

此版本尚未生成 AI 解读。解读由后台任务生成并按论文版本保存,登录后共享已有结果。

版本差异

本站首次收录为 v2,暂无更早版本可对照。

观测到的版本

相邻记录可能跳过中间版本;首次发现 v2 及以上也会标为版本更新。

v2 · 2026-11-18 13:43 · 最新观测版本

Auditing Path-Specific Fairness Across Causal Discovery Algorithms: A Heart Failure Case Study

Causal discovery is increasingly applied to healthcare data, where the recovered relationships can encode biased pathways that propagate to downstream prediction. Path-specific fairness analysis, through direct, indirect, and spurious effect decompositions along with fairness-utility ratio assessment allows bias quantification and associated prediction cost. However, existing evaluations of causal discovery under fairness constraints have largely used non-clinical datasets and have not separated the contribution of confounders from that of mediators, leaving open how discovery-algorithm choice propagates through path-specific fairness to the utility trade-off in clinical settings. This work addresses that gap by establishing an expert-elicited causal graph benchmark for the heart failure clinical records dataset and tracing discovery algorithms through composite, per-variable fairness decompositions and fairness-utility ratio. ICA-LiNGAM achieves the lowest structural Hamming distance and highest recall, while GES achieves the highest precision. For path-specific effects, there was a 1.2 percentage-point difference in the mediated effect on ejection fraction on overall causal fairness between the original and discovered graphs. This ultimately led to variations in the fairness-utility ratio highlighting need for fine-grained evaluation. These results indicate that discovery-aware, path-specific fairness evaluation is consequential in clinical settings and warrants inclusion in routine auditing of clinical risk models.

查看此版本解读 →查看此版本原文 ↗